- Previous Close
0.00 - Open
75.25 - Bid 83.13 x 38500
- Ask 88.23 x 34100
- Day's Range
75.25 - 75.25 - 52 Week Range
75.25 - 75.25 - Volume
800 - Avg. Volume
0 - Market Cap (intraday)
4.024B - Beta (5Y Monthly) 0.18
- PE Ratio (TTM)
20.23 - EPS (TTM)
3.72 - Earnings Date Mar 11, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Apr 12, 2024
- 1y Target Est
--
Galenica AG operates as a healthcare service provider in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands. This segment also offers medication for treatment of patients at home; launches and distributes a portfolio of consumer health, pharmaceutical, and parapharmaceutical products; and marketing and sale services to partners in the healthcare market. The Logistics & IT segment provides range of specialized pre-wholesale services, including storage, distribution, and debt collection to pharmaceutical and healthcare companies. This segment also offers master data system for the healthcare market; develops management solutions for the healthcare market; group internal IT services; and publishes printed and electronic technical information on pharmaceutical products, as well as complete management solutions for pharmacies. The company was founded in 1927 and is headquartered in Bern, Switzerland.
www.galenica.com7,955
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: GALNF
View MorePerformance Overview: GALNF
Trailing total returns as of 12/13/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GALNF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GALNF
View MoreValuation Measures
Market Cap
4.19B
Enterprise Value
4.38B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
4.66%
Return on Assets (ttm)
4.34%
Return on Equity (ttm)
12.45%
Revenue (ttm)
3.8B
Net Income Avi to Common (ttm)
169.68M
Diluted EPS (ttm)
3.72
Balance Sheet and Cash Flow
Total Cash (mrq)
69.55M
Total Debt/Equity (mrq)
60.33%
Levered Free Cash Flow (ttm)
155.85M